Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting provided a platform for interaction and exchange among basic scientists and clinicians in breast cancer. Highlights from this hybrid meeting include the latest Phase III data for the use of SERDs for HR+/HER2- disease, updates on the use of IO in TNBC as well as the importance of tackling disparities in breast cancer treatment and survival outcomes.
View all videos

SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting
07–10 December 2021 | San Antonio, TX

📢With the 2024 @ASCO Annual Meeting only 3 weeks away, we’re gearing up to provide you exclusive, up-to-date coverage!

Join us at http://VJOncology.com for key updates on #Oncology innovation and research!

#ASCO24

May is #BladderCancerMonth24 and watch out for our weekly podcast on our website this Friday with our special guest Rob Jones, who will talk on:

⭐#Bladdercancer management in the UK
⭐Improving 1L treatment in BC
⭐Survivorship challenges

Here's a 30 sec preview🎙️

#blcsm

Join us for our Post-ASCO 2024 Highlights 📣🩸

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agendas available soon 📝

REGISTER 👉 https://www.vjoncology.com/feature/post-asco-2024-highlights/

#ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1

⏰ #ESMOBreast24 is just a week away!

We’re excited to bring you the latest news in #breastcancer at http://VJOncology.com, and follow us @VJOncology for exclusive interviews with experts, podcasts, and more!

@‌myESMO #bcsm

Load More

SABCS 2021

The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting
07–10 December 2021 | San Antonio, TX
The San Antonio Breast Cancer Symposium (SABCS) 2021 Annual Meeting provided a platform for interaction and exchange among basic scientists and clinicians in breast cancer. Highlights from this hybrid meeting include the latest Phase III data for the use of SERDs for HR+/HER2- disease, updates on the use of IO in TNBC as well as the importance of tackling disparities in breast cancer treatment and survival outcomes.
View all videos

📢With the 2024 @ASCO Annual Meeting only 3 weeks away, we’re gearing up to provide you exclusive, up-to-date coverage!

Join us at http://VJOncology.com for key updates on #Oncology innovation and research!

#ASCO24

May is #BladderCancerMonth24 and watch out for our weekly podcast on our website this Friday with our special guest Rob Jones, who will talk on:

⭐#Bladdercancer management in the UK
⭐Improving 1L treatment in BC
⭐Survivorship challenges

Here's a 30 sec preview🎙️

#blcsm

Join us for our Post-ASCO 2024 Highlights 📣🩸

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦

Agendas available soon 📝

REGISTER 👉 https://www.vjoncology.com/feature/post-asco-2024-highlights/

#ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1

⏰ #ESMOBreast24 is just a week away!

We’re excited to bring you the latest news in #breastcancer at http://VJOncology.com, and follow us @VJOncology for exclusive interviews with experts, podcasts, and more!

@‌myESMO #bcsm

Load More